Pertactin-deficient
Antigens, Bacterial
/ genetics
Bacterial Outer Membrane Proteins
Bordetella pertussis
/ genetics
Enzyme-Linked Immunosorbent Assay
Europe
/ epidemiology
Humans
Pertussis Toxin
/ genetics
Pertussis Vaccine
/ immunology
Time Factors
Vaccines, Acellular
/ immunology
Virulence Factors, Bordetella
/ genetics
Whooping Cough
/ diagnosis
acellular vaccine
pertactin
pertussis
vaccination, Europe
Journal
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
entrez:
21
2
2019
pubmed:
21
2
2019
medline:
17
7
2020
Statut:
ppublish
Résumé
IntroductionPertussis outbreaks have occurred in several industrialised countries using acellular pertussis vaccines (ACVs) since the 1990s. High prevalence of pertactin (PRN)-deficient
Identifiants
pubmed: 30782265
doi: 10.2807/1560-7917.ES.2019.24.7.1700832
pmc: PMC6381657
doi:
Substances chimiques
Antigens, Bacterial
0
Bacterial Outer Membrane Proteins
0
Pertussis Vaccine
0
Vaccines, Acellular
0
Virulence Factors, Bordetella
0
pertactin
63GD90PP8X
Pertussis Toxin
EC 2.4.2.31
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Nat Genet. 2003 Sep;35(1):32-40
pubmed: 12910271
J Clin Microbiol. 2007 Oct;45(10):3257-62
pubmed: 17699646
BMC Microbiol. 2008 Sep 25;8:162
pubmed: 18816412
New Microbiol. 2009 Apr;32(2):159-66
pubmed: 19579693
Vaccine. 2009 Oct 9;27(43):6034-41
pubmed: 19666155
PLoS One. 2012;7(2):e31985
pubmed: 22348138
PLoS One. 2012;7(4):e35874
pubmed: 22558249
Clin Microbiol Infect. 2012 Sep;18(9):E340-6
pubmed: 22717007
Clin Vaccine Immunol. 2012 Oct;19(10):1703-4
pubmed: 22914363
J Clin Microbiol. 2013 Feb;51(2):422-8
pubmed: 23175253
Vaccine. 2013 Sep 23;31(41):4541-7
pubmed: 23933365
Vaccine. 2013 Oct 25;31(45):5178-91
pubmed: 23994021
Euro Surveill. 2013 Sep 19;18(38):null
pubmed: 24084340
PLoS One. 2013 Oct 04;8(10):e77165
pubmed: 24124606
Clin Vaccine Immunol. 2014 Feb;21(2):119-25
pubmed: 24256623
Emerg Infect Dis. 2014 Apr;20(4):626-33
pubmed: 24655754
J Immunol Methods. 2014 Jun;408:142-8
pubmed: 24925807
Expert Rev Vaccines. 2014 Sep;13(9):1135-46
pubmed: 24953157
Euro Surveill. 2014 Aug 21;19(33):null
pubmed: 25166348
Clin Infect Dis. 2015 Jan 15;60(2):223-7
pubmed: 25301209
MMWR Morb Mortal Wkly Rep. 2014 Dec 5;63(48):1129-32
pubmed: 25474033
Eur J Clin Microbiol Infect Dis. 2015 Apr;34(4):821-30
pubmed: 25527446
Pathog Dis. 2015 Oct;73(7):null
pubmed: 26208655
Vaccine. 2015 Nov 17;33(46):6277-81
pubmed: 26432908
Genome Announc. 2015 Nov 25;3(6):null
pubmed: 26607899
Emerg Infect Dis. 2016 Feb;22(2):319-322
pubmed: 26812174
Clin Microbiol Rev. 2016 Jul;29(3):449-86
pubmed: 27029594
J Bacteriol. 2017 Mar 28;199(8):
pubmed: 28167525
Emerg Infect Dis. 2017 Apr;23(4):699-701
pubmed: 28322702
Vaccine. 2017 Sep 18;35(39):5249-5255
pubmed: 28823620
Infect Immun. 1998 Feb;66(2):670-5
pubmed: 9453625